Investigational Drug Dapagliflozin For Diabetes Meets Study Goals After 24-Week Phase 3 Study

Podiatry Arena Investigational Drug Dapagliflozin For Diabetes Meets Study Goals After 24-Week Phase 3 Study

Welcome to the Podiatry Arena forums, for communication between foot health professionals about podiatry and related topics.

You are currently viewing our podiatry forum as a guest which gives you limited access to view all podiatry discussions and access our other features. By joining our free global community of Podiatrists and other interested foot health care professionals you will have access to post podiatry topics (answer and ask questions), communicate privately with other members (PM), upload content, view attachments, receive a weekly email update of new discussions, earn CPD points and access many other special features. Registered users do not get displayed the advertisments in posted messages. Registration is fast, simple and absolutely free so please, join our global Podiatry community today!

If you have any problems with the registration process or your account login, please contact contact us.

Investigational Drug Dapagliflozin For Diabetes Meets Study Goals After 24-Week Phase 3 Study

Submit Thread >

< Submit Thread

Thread Tools

Display Modes

20th September 2010, 01:10 PM

RSSFeedBot RSSFeedBot is offline

I, Robot

About:

Join Date: Jul 2008

Posts: 10,131

Join Date: Jul 2008

Marketplace reputation 0% (0)

CPD Points: 1

Thanks: 0

Thanked 22 Times in 22 Posts

Investigational Drug Dapagliflozin For Diabetes Meets Study Goals After 24-Week Phase 3 Study

Podiatry Arena members do not see these ads

Dapagliflozin when added to existing glimepiride (sulphonylurea) therapy significantly reduced HbA1C (glycosylated hemoglobin) in adults with Type 2 Diabetes, compared to patients taking glimepiride plus a placebo, a 24-week Phase 3 Study revealed. In a joint announcement, Astra Zeneca PLC. and Bristol-Myers Squibb Company said the trial met the study goals...

More...

Sponsored Links

« Previous Thread | Next Thread »

Thread Tools
Show Printable Version Email this Page
Display Modes
Linear Mode Switch to Hybrid Mode Switch to Threaded Mode

Posting Rules
You may not post new threads You may not post replies You may not post attachments You may not edit your posts	vB code is On Smilies are On [IMG] code is On HTML code is On

Forum Jump

Translate This Page

Similar Threads

Thread	Thread Starter	Forum	Replies	Last Post
Unigene Reports Continuation Of Phase III Study Of Oral Calcitonin In Osteoarthritis Patients	RSSFeedBot	Latest Rheumatology News	0	27th July 2010 03:20 AM
BioCryst Announces Initiation of Phase 2 Study of BCX4208 for the Treatment of Gout	RSSFeedBot	Gout Online	0	30th September 2009 11:20 PM
Ustekinumab In The Treatment Of Psoriatic Arthritis: Investigational Study Published	RSSFeedBot	Latest Rheumatology News	0	16th March 2009 03:30 PM
Insulin Drug Study Shows Significant Improvements In More Than 52,000 Diabetic Patients	RSSFeedBot	Latest Diabetes Medicine Research & News	0	2nd March 2009 10:10 AM
CrystalGenomics Announces Positive Phase IIa Results For Osteoarthritis Study Of CG100649	RSSFeedBot	Latest Rheumatology News	0	23rd December 2008 05:30 AM

New To Site?	Need Help?
Register to Participate View Forum Leaders Contact Us	Frequently Asked Questions Did you forget your password? Mark Forums Read

Finding your way around:

Browse the forums.

Search the site.

Browse the tags.

Search the tags.

All times are GMT -7. The time now is 01:58 AM.

User Name		Remember Me?
Password